These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30017800)
1. Testosterone treatment in older men: clinical implications and unresolved questions from the Testosterone Trials. Yeap BB; Page ST; Grossmann M Lancet Diabetes Endocrinol; 2018 Aug; 6(8):659-672. PubMed ID: 30017800 [TBL] [Abstract][Full Text] [Related]
2. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men. Borst SE; Yarrow JF Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953 [TBL] [Abstract][Full Text] [Related]
3. Reflections on the T Trials. Swerdloff R; Wang C Andrology; 2020 Nov; 8(6):1512-1518. PubMed ID: 32902162 [TBL] [Abstract][Full Text] [Related]
4. Effects of long-term testosterone administration on cognition in older men with low or low-to-normal testosterone concentrations: a prespecified secondary analysis of data from the randomised, double-blind, placebo-controlled TEAAM trial. Huang G; Wharton W; Bhasin S; Harman SM; Pencina KM; Tsitouras P; Li Z; Hally KA; Asthana S; Storer TW; Basaria S Lancet Diabetes Endocrinol; 2016 Aug; 4(8):657-665. PubMed ID: 27377542 [TBL] [Abstract][Full Text] [Related]
5. Hypotestosteronaemia in the aging male: should we treat it? Christe N; Meier CA Swiss Med Wkly; 2015; 145():w14216. PubMed ID: 26599486 [TBL] [Abstract][Full Text] [Related]
6. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798 [TBL] [Abstract][Full Text] [Related]
7. Testosterone Replacement in Men with Age-Related Low Testosterone: What Did We Learn From The Testosterone Trials? Matsumoto AM Curr Opin Endocr Metab Res; 2019 Jun; 6():34-41. PubMed ID: 32043015 [TBL] [Abstract][Full Text] [Related]
8. Benefits and Risks of Testosterone Treatment of Older Men with Hypogonadism. Galbiati FF; Goldman AL; Gattu A; Guzelce EC; Bhasin S Urol Clin North Am; 2022 Nov; 49(4):593-602. PubMed ID: 36309416 [TBL] [Abstract][Full Text] [Related]
9. Lessons From the Testosterone Trials. Snyder PJ; Bhasin S; Cunningham GR; Matsumoto AM; Stephens-Shields AJ; Cauley JA; Gill TM; Barrett-Connor E; Swerdloff RS; Wang C; Ensrud KE; Lewis CE; Farrar JT; Cella D; Rosen RC; Pahor M; Crandall JP; Molitch ME; Resnick SM; Budoff M; Mohler ER; Wenger NK; Cohen HJ; Schrier S; Keaveny TM; Kopperdahl D; Lee D; Cifelli D; Ellenberg SS Endocr Rev; 2018 Jun; 39(3):369-386. PubMed ID: 29522088 [TBL] [Abstract][Full Text] [Related]
11. Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). Rosen RC; Wu F; Behre HM; Porst H; Meuleman EJH; Maggi M; Romero-Otero J; Martinez-Salamanca JI; Jones TH; Debruyne FMJ; Kurth KH; Hackett GI; Quinton R; Stroberg P; Reisman Y; Pescatori ES; Morales A; Bassas L; Cruz N; Cunningham GR; Wheaton OA; J Sex Med; 2017 Sep; 14(9):1104-1115. PubMed ID: 28781213 [TBL] [Abstract][Full Text] [Related]
12. Testosterone treatment in the aging male: myth or reality? Nigro N; Christ-Crain M Swiss Med Wkly; 2012; 142():w13539. PubMed ID: 22430839 [TBL] [Abstract][Full Text] [Related]
13. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism. Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499 [TBL] [Abstract][Full Text] [Related]
14. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men. Traish AM Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108 [TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy: For whom, when and how? Tsametis CP; Isidori AM Metabolism; 2018 Sep; 86():69-78. PubMed ID: 29530796 [TBL] [Abstract][Full Text] [Related]
16. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial. Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318 [TBL] [Abstract][Full Text] [Related]
17. Hypogonadism and male obesity: Focus on unresolved questions. Grossmann M Clin Endocrinol (Oxf); 2018 Jul; 89(1):11-21. PubMed ID: 29683196 [TBL] [Abstract][Full Text] [Related]